aTyr Pharma secured US $49 million equity financing from new and existing investors. California-based aTyr Pharma said it closed US $49 million in equity financing, which will be used to finance clinical trials to address rare autoimmune diseases.
Healthcare Health/Fitness
RoundTable Healthcare Partner acquires SCN
RoundTable Healthcare Partner stated that it had acquired Santa Cruz Nutritionals from Levine Leichtman Capital Partners.
Agios Pharmaceuticals concludes initial public offering of 6.7 mln shares
Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday. Agios Pharmaceuticals Inc. announced the conclusion of its initial public offering (IPO) of 6,772,221 shares of the company's common stock at a final offering price of US$18 per share.
Venture capital pours in GBP 150,000 to biotech startup
Venture capital firm Mercia Fund Management gives a GBP 150,000 funding to startup biotech company Oxford Genetics.
Abraaj Group sells stake in insurer’s service firm to Malaysian state-investment fund
Abraaj Group sells its 50% stake in health insurance provider Acıbadem Sağlık ve Hayat Sigorta. The Abraaj Group on Monday announced that it is selling its stake in Acıbadem Sağlık ve Hayat Sigorta A.
Latest News
Marlin Equity Partners infused SigmaCare with fresh equity funding. Marlin Equity Partners recently backed SigmaCare with fresh equity funding. No financial details were disclosed, but SigmaCare CEO Steve Pacicco said the funds will be used for expansion.
Valeant Pharmaceuticals said it expected to save more than USD 800 million when it buys Bausch & Lomb.
UK-based PolyTherics Limited merges with Antitope Limited to create a better group that can develop better pharmaceuticals.
Perrigo Company announced today that it has signed a definitive acquisition agreement to acquire Irish drug firm Elan Corporation.
aTyr Pharma reveals that it had secured up to US$59 million in financing from current investors and an anonymous global public investment fund.
Perrigo Co is now in a waiting game as it waits for the decision regarding the acquisition of Elan Corp.
K Ganesh and MeenaGanesh have announced they they have bought Portea Medical. K Ganesh and MeenaGanesh, both Serial tech entrepreneurs, announced that they have acquired Portea Medical, a New Delhi-based healthcare firm.
The GlaxoSmithKline controversy opened the doors of investigation about the misconduct happening in the pharmaceutical industry.
Herve Gisserot replaces Mark Reilly as GSK's head of operations in China in the wake of the bribery scandal faced by the pharmaceutical company.
